Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy

Spurred by newly developed drug delivery systems (DDSs), side effects of cancer chemotherapy could be reduced by using multifunctional nanoplatforms. However, the facile synthesis of effective DDSs remains a challenge. Here, a six-arginine-tailed anti-epidermal growth factor receptor (EGFR) affibody...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Control Release
Egile Nagusiak: Zhao, Ning, Ding, Bingbing, Zhang, Ying, Klockow, Jessica L., Lau, Ken, Chin, Frederick T., Cheng, Zhen, Liu, Hongguang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006592/
https://ncbi.nlm.nih.gov/pubmed/32450093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.05.031
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak